About this trial
This study explores an intervention to support people in Israel who are living with chronic health conditions such as cancer or after kidney transplantation. It focuses on a well-known international program called the Chronic Disease Self-Management Program (CDSMP), which was developed at Stanford University. The program helps individuals build confidence and skills to better manage their health, feel more in control, and improve their day-to-day quality of life.
Participants will take part in a six-week group program, delivered online, where they will learn practical strategies for managing symptoms like fatigue or pain, setting achievable health goals, communicating effectively with healthcare professionals, and staying active and engaged. The sessions are guided by trained facilitators and include support from others facing similar health challenges.
The study will involve surveys before and after the program, as well as a follow-up six months later, to understand how the program may have helped participants. Some participants will also be invited to share their experiences in small discussion groups.
By testing this program in Israel, the researchers hope to learn how it can be adapted and offered more widely to help others living with chronic conditions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 21 years or older
Diagnosed with at least one chronic disease (as documented in the medical record)
Community-dwelling
Fluent in Hebrew
Disqualifiers
Documented cognitive impairment
Diagnosis of major depression or other psychiatric disorder (based on self-report or medical records)
Hospitalization in the past 3 months
Trial design
Single group
Treatments tested in this trial
Chronic Disease Self-Management Program (CDSMP)
BehavioralA structured, peer-led, six-week online intervention developed at Stanford University to enhance self-management skills in individuals with chronic conditions. Sessions include action planning, symptom management, medication adherence, healthy behaviors, and emotional coping.
Treatment groups
Trial outcomes
Primary outcomes
Patient Activation Measure (PAM-13)
The Patient Activation Measure (PAM-13) is a validated self-report questionnaire that assesses individuals' knowledge, skills, and confidence in managing their health. Higher scores reflect greater activation and self-management ability.
health-related behaviors
Assessed using a custom self-report questionnaire developed by the research team, covering physical activity, nutrition, medication adherence, and use of health services.
chronic disease symptom burden
Evaluated using the Self-Management Resource Center (SMRC) symptom survey, which includes ratings of fatigue, pain, emotional distress, sleep, depression, anxiety, and social isolation.
health-related quality of life (EQ-5D)
Baseline, immediately post-intervention, 6-month follow-up
Secondary outcomes
Themes from focus group analysis regarding participant experience
Semi-structured focus groups will be conducted with a subset of participants to explore their perceptions of the program's relevance, usefulness, cultural fit, and overall impact on daily life. Audio recordings will be transcribed and analyzed thematically using a structured multi-stage coding process.
Perceived facilitators and barriers to self-management
Identified from qualitative data in focus group discussions. Participants will describe what helped or hindered their ability to engage in self-management behaviors following the intervention.
Participant suggestions for improving the CDSMP
Within one month after program completion
Sponsors and contacts
Click on the lead sponsor to view all of their trials.